Connect with us

Company News

AVITA Medical appoints James Corbett as CEO

AVITA Medical, Inc., a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, announced today the appointment of James Corbett as Chief Executive Officer, effective immediately. Corbett, who has served as a non-executive member of the Board of Directors, will continue as an executive member of the Board of Directors of AVITA Medical, Inc.

Corbett, has nearly 40 years of experience in the Life Sciences field, having served as CEO of multiple publicly traded companies, including: Microtherapeutics Inc., ev3 Inc and Alphatec Spine. Corbett has extensive global, commercial, and operational experience, having served as an expatriate General Manager of Baxter Japan, followed by leading the global commercialization as General Manager and President of Scimed Life Systems and Boston Scientific International respectively. Corbett later led the development and IPO of ev3 Inc. and has served as CEO of three privately held companies; Home Diagnostics Inc., Vertos Medical Inc. and CathWorks LTD.

“Jim is an experienced strategist with significant commercial expertise that positions him well to lead AVITA Medical through its next stage of growth and beyond,” said Lou Panaccio, Chairman of the Board of AVITA Medical. “Having run a thorough process utilizing a leading executive search firm, I am confident that Jim is the right leader for the Company at this time.”

“The opportunities presented by the RECELL® System and expected expansion of indications makes this a particularly exciting time to be a part of the executive team at AVITA Medical,” said Corbett. “We are well positioned to execute on a commercial growth strategy with imminent new indications that will allow us to continue improving the lives of and outcomes for our patients.”

Corbett will succeed Dr Michael Perry, who has served as Executive Director and Chief Executive Officer of the Company since June 2017.

“We are grateful to Dr Perry for his many contributions to AVITA Medical,” said Panaccio. “We thank him for his commitment to AVITA Medical, its customers, employees, shareholders, and the patients we serve.”
MB Bureau

error: Content is protected !!